Literature DB >> 224858

Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities.

S Utsumi, S Sonoda, T Imagawa, M Kanoh.   

Abstract

A new factor that inhibited phagocytosis to opsonized targets and chemotaxis of PMN was extracted from B. pertussis cells, and named PMN-inhibitory factor (PIF). Cells in phase I produced 10 times more PIF than those in phase III, and like other phase I-associated components--the hemagglutinin, the histamine-sensitizing factor and agglutinogens--PIF showed degenerative, phenotypic variation during in vitro culture of phase I bacteria. PIF was partially purified by four steps, including adsorption chromatography on Dansyl-aminononamethylene Sepharose. The resulting fraction was heterogeneous but showed little histamine-sensitizing and cytotoxic activities and was free from LPS, the hemagglutinin and a leukocyte agglutinin. The inherent resistance of B. pertussis cells, in either phase I or III, as demonstrated also in the present study, and PIF-mediated defiance against immunological defense mechanism may constitute a complex host-parasite relation in experimental infections with B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 224858

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  9 in total

Review 1.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.

Authors:  R L Friedman; R L Fiederlein; L Glasser; J N Galgiani
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

4.  Novel biological property of pertussis toxin: chemotactic activity on human monocytes.

Authors:  T Ogawa; H Takada; S Kotani; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  [Research on whooping cough vaccine].

Authors:  C R Manclark
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

6.  Pertussis vaccine research.

Authors:  C R Manclark
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin.

Authors:  D Torre; F Speranza; A Pugliese; R Tambini
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

8.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography.

Authors:  R L Friedman
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.